Abstract: A photopolymerizable inkjet ink including: at least one selected from the group consisting of (meth)acrylic acid esters negative for skin sensitization and (meth)acrylamides negative for skin sensitization; and at least one selected from the group consisting of vinyl ethers negative for skin sensitization, t-butyl methacrylate negative for skin sensitization, n-pentyl methacrylate negative for skin sensitization, and n-hexyl methacrylate negative for skin sensitization.

Abstract: A photopolymerizable inkjet ink including: a photopolymerizable monomer having a Stimulation Index (SI value) of less than 3, where the Stimulation Index indicates the extent of sensitization as measured by a skin sensitization test based on Local Lymph Node Assay; and a phenol aromatic compound having two hydroxyl groups in the molecule thereof.

Abstract: An active energy ray-curable ink which contains: polymerizable compounds containing a monofunctional polymerizable monomer a homopolymer of which has Tg of 90° C. or higher, wherein a cured product obtained by forming a coating film having an average thickness of 10 ?m on a polycarbonate substrate using the ink, and 15 seconds later, and applying active energy rays having a light quantity of 1,500 mJ/cm2 to the coating film to cure satisfies the following (1) and (2): (1) a stretchability of the cured product represented by the following equation is 2 or greater, when the cured product is stretched by a tensile tester at a tensile speed of 20 mm/min, and temperature of 180° C., and Stretchability=(length after tensile test)/(length before tensile test) (2) adhesion between the substrate and the cured product as measured by a cross-cut test in accordance with JIS K5400 is 70 or greater.

Abstract: Provided is an active energy ray-curable inkjet ink containing at least photopolymerizable compounds. The photopolymerizable compounds include: at least one monofunctional monomer selected from the group consisting of a monofunctional monomer of which homopolymer has a glass transition temperature of 90° C. or higher, a monofunctional monomer having a ring structure, and a monofunctional monomer of which homopolymer has a glass transition temperature of 90° C. or higher and that has a ring structure; and urethane (meth)acrylate.

Abstract: To provide a photopolymerizable composition, which includes photopolymerizable monomers containing glycerol dimethacrylate, caprolactone-modified dipentaerythritol hexaacrylate, and diethylene glycol dimethacrylate, wherein an amount of the glycerol dimethacrylate in the photopolymerizable monomers is 25% by mass or greater.

Abstract: A photopolymerizable composition contains diethylene glycol dimethacrylate, b1, b2, and b3, wherein the content of b2 is less than 2.5% by weight, the content of b3 is less than 3% by weight. b1 is 1-[4-(2-hydroxyethoxy)-phenyl]-2-hydroxy-2-methyl-1-propane-1-on, b2 is 2-hydroxy-1-{4-[4-(2-hydroxy-2-methyl-propionyl)benzyl]phenyl}-2-methyl-1-propane-1-on, and b3 is oligo{2-hydroxy-2-methyl-1-[4-(1-methylvinyl)phenyl]propanone}.

Abstract: An active energy ray curing type composition contains (meth)acrylic acid ester; and polyether-modified polysiloxane, wherein (meth)acrylic acid ester comprises diethylene glycol dimethacrylate and alkoxy-modified (meth)acrylic acid ester.

Abstract: An active energy ray-curable ink which contains: polymerizable compounds containing a monofunctional polymerizable monomer a homopolymer of which has Tg of 90° C. or higher, wherein a cured product obtained by forming a coating film having an average thickness of 10 ?m on a polycarbonate substrate using the ink, and 15 seconds later, and applying active energy rays having a light quantity of 1,500 mJ/cm2 to the coating film to cure satisfies the following (1) and (2): (1) a stretchability of the cured product represented by the following equation is 2 or greater, when the cured product is stretched by a tensile tester at a tensile speed of 20 mm/min, and temperature of 180° C., and Stretchability=(length after tensile test)/(length before tensile test) (2) adhesion between the substrate and the cured product as measured by a cross-cut test in accordance with JIS K5400 is 70 or greater.

Abstract: A non-aqueous photopolymerizable inkjet ink, including as a photopolymerizable monomer: (a) ethylene glycol dimethacrylate; and (b) caprolactone-modified dipentaerythritol hexaacrylate or ethylene oxide-modified trimethylolpropane tri-methacrylate, or both thereof, wherein the ink includes the (a) component by 10% by mass to 95% by mass with respect to the entire photopolymerizable monomer, and the ink includes the (b) component by 5% by mass to 90% by mass with respect to the entire photopolymerizable monomer, and wherein the ink does not include a diluting solvent.

Abstract: A transdermal patch for the treatment of Alzheimer's disease includes: a backing, a rivastigmine-containing layer, a pressure-sensitive adhesive layer, and a release liner. In the transdermal patch, the rivastigmine-containing layer contains rivastigmine and an alkyl(meth)acrylate resin, the pressure-sensitive adhesive layer is composed of an acrylic pressure-sensitive adhesive containing a (meth)acrylic acid ester having a hydroxyl group, and neither the rivastigmine-containing layer nor the pressure-sensitive adhesive layer contains an anti-oxidizing agent.

Abstract: To provide a photopolymerizable inkjet ink including: diethylene glycol dimethacrylate; caprolactone-modified dipentaerythritol hexaacrylate; and a photopolymerization initiator represented by the following general formula (1): where X1 is represented by the following general formula (1-1), and X2 is represented by the following general formula (1-2): where R1 to R4 are each independently a C1-C6 alkyl group, and R1 and R2 may be linked to form a ring, and R3 and R4 may be linked to form a ring; Z1 and Z2 is —NR5R6 or OR7; R5 and R6 are each independently a C1-C6 alkyl group, and R5 and R6 may be linked to form a ring; and R7 is a hydrogen atom, a methyl group, or a trimethylsilyl group.

Abstract: An optically polymerizable inkjet ink including an optically polymerizable monomer having a Stimulation Index (SI) of less than 3 in a skin sensitization test as measured by Local Lymph Node Assay (LLNA), a molecule cleavage type optical polymerization initiator, a hydrogen-extracting type optical polymerization initiator, and an amine compound serving as a polymerization accelerator.

Abstract: A polymerizable ink composition contains polymerizable monomers containing at least one of an acrylic acid ester compound, a methacrylic acid ester compound, an acryl amide, and a methacryl amide; and a vinyl ether compound; and one of potassium oxide and sodium oxide.

Abstract: An improved polymerizable ink composition contains polymerizable monomers containing one or both of an acrylic acid ester compound and a methacrylic acid ester compound and a vinyl ether compound; an alkali component; and an aromatic secondary amine compound.

Abstract: To provide a photopolymerizable inkjet ink, which contains monomer components, and a polymer or a copolymer of styrene, styrene derivative, acrylic acid ester, or acrylic acid, or any combination thereof, wherein the monomer components contain: t-butyl methacrylate, n-pentyl methacrylate, or n-hexyl methacrylate, or any combination thereof; and glycerol dimethacrylate, and wherein the photopolymerizable inkjet ink is free from a diluting solvent.

Abstract: A photopolymerizable composition includes glyceryl monomethacrylate in an amount of from 25 to 100 parts by weight per 100 parts by weight of monomers.

Abstract: A photopolymerizable composition includes diethyleneglycol dimethacrylate, 1-hydroxy-cyclohexyl-phenyl-ketone, 2-hydroxy-1-{4-[4-(2-hydroxy-2-methyl-propionyl)benzyl]phenyl}-2-methyl-1-propane-1-one and 2-[2-hydroxy-4-(1-octyloxycarbonylethoxy)phenyl]-4,6-bis(4-phenyl)-4,6-bis)4-phenylphenyl-1,3,5-triazine.

Abstract: A photopolymerizable inkjet ink including: at least one selected from the group consisting of (meth)acrylic acid esters negative for skin sensitization and (meth)acrylamides negative for skin sensitization; and at least one selected from the group consisting of vinyl ethers negative for skin sensitization, t-butyl methacrylate negative for skin sensitization, n-pentyl methacrylate negative for skin sensitization, and n-hexyl methacrylate negative for skin sensitization.

Abstract: A photopolymerizable composition includes diethyleneglycol dimethacrylate and methacrylic acid ester having a phosphoric group.

Abstract: A transdermal patch for the treatment of Alzheimer's disease includes: a backing, a rivastigmine-containing layer, a pressure-sensitive adhesive layer, and a release liner. In the transdermal patch, the rivastigmine-containing layer contains rivastigmine and an alkyl (meth)acrylate resin, the pressure-sensitive adhesive layer is composed of an acrylic pressure-sensitive adhesive containing a (meth)acrylic acid ester having a hydroxy group, and neither the rivastigmine-containing layer nor the pressure-sensitive adhesive layer contains an anti-oxidizing agent.